Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05148572
What this trial is testing

Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 101
Testing effectiveness (Phase 2)Ended earlyNCT01832857
What this trial is testing

Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients

Who this might be right for
Cancer
Cornerstone Pharmaceuticals 7
Not applicableLooking for participantsNCT07303712
What this trial is testing

Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90

Who this might be right for
Hepatocellular Carcinoma (HCC)
Palo Alto Veterans Institute for Research 12
Early research (Phase 1)Active Not RecruitingNCT05097911
What this trial is testing

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
National University Hospital, Singapore 33
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Not applicableStudy completedNCT00950144
What this trial is testing

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Who this might be right for
Colorectal CancerDepressionFatigue+3 more
City of Hope Medical Center 123
Testing effectiveness (Phase 2)Ended earlyNCT01381211
What this trial is testing

Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Ghent 72
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Not applicableUnknownNCT03326375
What this trial is testing

Comparison of SBRTand Repeat TACE for HCC

Who this might be right for
HepatoCellular Carcinoma
Gangneung Asan Hospital 80
Not applicableLooking for participantsNCT07305428
What this trial is testing

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

Who this might be right for
HCC - Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma
The University of Hong Kong 30
Large-scale testing (Phase 3)UnknownNCT04053972
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 377
Not applicableStudy completedNCT07386639
What this trial is testing

Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver CancerNeoplasm Metastasis
Tongji University 19,019
Testing effectiveness (Phase 2)UnknownNCT04435977
What this trial is testing

Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocarcinoma
Istituto Clinico Humanitas 46
Testing effectiveness (Phase 2)Study completedNCT01352728
What this trial is testing

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 50
Testing effectiveness (Phase 2)Looking for participantsNCT06954467
What this trial is testing

JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 72
Testing effectiveness (Phase 2)Study completedNCT03516071
What this trial is testing

Brivanib in Chinese Patients With Previously Treated Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Early research (Phase 1)UnknownNCT05363722
What this trial is testing

A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 80
Testing effectiveness (Phase 2)UnknownNCT06040177
What this trial is testing

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombusImmune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University 30
Next Page